Patents by Inventor Thomas CIULLA

Thomas CIULLA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING CHRONIC THYROID EYE DISEASE
    Publication number: 20260132206
    Abstract: Methods of treating patients with chronic thyroid eye disease are provided for herein, such as by administering antibodies and compositions that bind to and/or antagonize IGF-1R.
    Type: Application
    Filed: January 7, 2026
    Publication date: May 14, 2026
    Applicant: Viridian Therapeutics, Inc.
    Inventor: Thomas CIULLA
  • COMPOSITIONS AND METHODS FOR TREATING MACULAR EDEMA ASSOCIATED WITH UVEITIS
    Publication number: 20250177417
    Abstract: The present invention relates to methods, devices, and compositions for treating macular edema associated with non-infectious uveitis. For example, the methods include treatment of certain populations of subjects having macular edema associated with non-infectious uveitis by administering to the subjects a triamcinolone composition via non-surgical administration to the suprachoroidal space (SCS) of the eye.
    Type: Application
    Filed: January 5, 2023
    Publication date: June 5, 2025
    Inventors: Thomas CIULLA, Shelley HANCOCK, Colette HALL, Barry KAPIK
  • COMPOSITIONS COMPRISING AXITINIB AND METHODS OF TREATING OCULAR DISORDERS
    Publication number: 20250025452
    Abstract: This disclosure is generally related to ophthalmic therapies, and more particularly to methods and devices that allow for infusion of a fluid drug formulation into posterior ocular tissues for targeted, localized treatment, for example, for the treatment of wet AMD in human patients. The drug formulation may be injected into the suprachoroidal space (SCS) or subretinal space of an eye. The drug formulation may include a tyrosine kinase inhibitor, such as axitinib.
    Type: Application
    Filed: July 18, 2024
    Publication date: January 23, 2025
    Inventors: Viral KANSARA, Thomas Ciulla, Colette Hall, Barry Kapik
  • COMPOSITIONS AND METHODS FOR TREATING OCULAR DISORDERS
    Publication number: 20230201371
    Abstract: The present invention relates to compositions and methods for treating ocular disorders. More specifically, the method includes non-surgical administration of gene therapies to the suprachoroidal space of the eye of a subject who is suffering from an ocular disorder.
    Type: Application
    Filed: March 18, 2021
    Publication date: June 29, 2023
    Inventors: Thomas CIULLA, Cherry WAN
  • COMPOSITIONS COMPRISING AXITINIB AND METHODS OF TREATING OCULAR DISORDERS
    Publication number: 20230089914
    Abstract: This disclosure is generally related to ophthalmic therapies, and more particularly to methods and devices that allow for infusion of a fluid drug formulation into posterior ocular tissues for targeted, localized treatment, for example, for the treatment of wet AMD in human patients. The drug formulation may be injected into the suprachoroidal space (SCS) or subretinal space of an eye. The drug formulation may include a tyrosine kinase inhibitor, such as axitinib.
    Type: Application
    Filed: February 19, 2021
    Publication date: March 23, 2023
    Inventors: Viral KANSARA, Thomas CIULLA, Colette HALL, Barry KAPIK